We are live on ! Find out more

1,619 hedge funds and large institutions have $126B invested in Merck in 2014 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 602 increasing their positions, 699 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 53

5% more funds holding in top 10

Funds holding in top 10: 140147 (+7)

0% more call options, than puts

Call options by funds: $950M | Put options by funds: $950M

0% less funds holding

Funds holding: 1,6211,619 (-2)

1% less capital invested

Capital invested by funds: $127B → $126B (-$978M)

1.04% less ownership

Funds ownership: 78.25%77.21% (-1%)

14% less repeat investments, than reductions

Existing positions increased: 602 | Existing positions reduced: 699

Holders
1,619
Holders Change
-2
Holders Change %
-0.12%
% of All Funds
46.95%
Holding in Top 10
147
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+5%
% of All Funds
4.26%
New
65
Increased
602
Reduced
699
Closed
53
Calls
$950M
Puts
$950M
Net Calls
+$352K
Net Calls Change
-$100M
Name Holding Trade Value Shares
Change
Change in
Stake
AQR Capital Management
76
AQR Capital Management
Connecticut
$262M +$60M +1,068,661 +30%
DL
77
Delta Lloyd
Netherlands
$257M -$20M -356,365 -24%
AAMU
78
Amundi Asset Management US
Massachusetts
$257M +$4.21M +74,904 +2%
RhumbLine Advisers
79
RhumbLine Advisers
Massachusetts
$256M -$5.48M -97,662 -2%
Principal Financial Group
80
Principal Financial Group
Iowa
$254M +$1.05M +18,690 +0.4%
State Board of Administration of Florida Retirement System
81
State Board of Administration of Florida Retirement System
Florida
$252M -$7.08M -126,053 -3%
Loomis, Sayles & Company
82
Loomis, Sayles & Company
Massachusetts
$251M -$2.75M -49,038 -1%
LSV Asset Management
83
LSV Asset Management
Illinois
$250M -$49.2M -876,678 -17%
SCCM
84
Schafer Cullen Capital Management
New York
$239M -$6.63M -118,085 -3%
Swiss National Bank
85
Swiss National Bank
Switzerland
$233M -$5.01M -89,184 -2%
TG
86
TCW Group
California
$227M +$5.43M +96,717 +2%
MTB
87
Mizuho Trust & Banking
Japan
$226M -$16.3M -290,407 -7%
RFC
88
Russell Frank Company
Washington
$223M -$47.3M -842,597 -18%
Barclays
89
Barclays
United Kingdom
$219M +$19.8M +352,653 +10%
State of Wisconsin Investment Board
90
State of Wisconsin Investment Board
Wisconsin
$210M -$14.8M -262,975 -7%
Thrivent Financial for Lutherans
91
Thrivent Financial for Lutherans
Minnesota
$207M -$5.48M -97,620 -3%
GE
92
General Electric
Ohio
$206M -$63.2M -1,124,669 -24%
BGIM
93
Brandywine Global Investment Management
Pennsylvania
$203M -$13M -230,990 -6%
Axa
94
Axa
France
$203M -$22.3M -396,908 -10%
Lazard Asset Management
95
Lazard Asset Management
New York
$201M -$21.9M -390,147 -10%
USAA
96
United Services Automobile Association
Texas
$198M +$5.48M +97,565 +3%
BJ
97
BlackRock Japan
Japan
$195M +$8.99M +160,146 +5%
BTS
98
BB&T Securities
Virginia
$169M -$526K -9,372 -3%
Citigroup
99
Citigroup
New York
$168M -$32.2M -573,157 -16%
PAM
100
Panagora Asset Management
Massachusetts
$166M +$9.03M +160,755 +6%

MRK Hedge Fund Activity: Q3 2014 in Review

1,619 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2014, worth a combined $126B — down 0.77% from $127B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new MRK positions and 53 closed out — a net gain of 12 holders — while 602 added to existing stakes and 699 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $434M. The largest seller was Norges Bank, cutting an estimated $1.3B.

  • 1,619 institutional investors held Merck (MRK) as of Q3 2014, down from 1,621 in Q2 2014.
  • Funds reported $126B of Merck stock for Q3 2014, down 0.77% quarter-over-quarter.
  • 65 funds opened new Merck positions in Q3 2014 and 53 closed out, a net change of +12 holders.
  • The largest Merck buyer in Q3 2014 was JP Morgan Chase, an estimated $434M added.
  • The largest Merck seller in Q3 2014 was Norges Bank, an estimated $1.3B sold.

Based on aggregated 13F filings for Q3 2014.